GoodRx Holdings, Inc. (GDRX)
3.56
+0.05
(+1.42%)
USD |
NASDAQ |
Nov 13, 16:00
3.55
-0.01
(-0.28%)
After-Hours: 19:59
GoodRx Holdings Enterprise Value : 1.454B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.454B |
| November 12, 2026 | 1.437B |
| November 11, 2026 | 1.484B |
| November 10, 2026 | 1.447B |
| November 09, 2026 | 1.484B |
| November 06, 2026 | 1.437B |
| November 05, 2026 | 1.430B |
| November 04, 2026 | 1.508B |
| November 03, 2026 | 1.430B |
| November 02, 2026 | 1.450B |
| October 30, 2026 | 1.430B |
| October 29, 2026 | 1.447B |
| October 28, 2026 | 1.423B |
| October 27, 2026 | 1.426B |
| October 26, 2026 | 1.454B |
| October 23, 2026 | 1.447B |
| October 22, 2026 | 1.474B |
| October 21, 2026 | 1.457B |
| October 20, 2026 | 1.440B |
| October 19, 2026 | 1.389B |
| October 16, 2026 | 1.386B |
| October 15, 2026 | 1.435B |
| October 14, 2026 | 1.392B |
| October 13, 2026 | 1.416B |
| October 12, 2026 | 1.426B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.409B |
| October 08, 2026 | 1.386B |
| October 07, 2026 | 1.348B |
| October 06, 2026 | 1.355B |
| October 05, 2026 | 1.386B |
| October 02, 2026 | 1.358B |
| October 01, 2026 | 1.355B |
| September 30, 2026 | 1.362B |
| September 29, 2026 | 1.341B |
| September 28, 2026 | 1.369B |
| September 25, 2026 | 1.382B |
| September 24, 2026 | 1.386B |
| September 23, 2026 | 1.372B |
| September 22, 2026 | 1.413B |
| September 21, 2026 | 1.396B |
| September 18, 2026 | 1.392B |
| September 17, 2026 | 1.399B |
| September 16, 2026 | 1.396B |
| September 15, 2026 | 1.430B |
| September 14, 2026 | 1.454B |
| September 11, 2026 | 1.396B |
| September 10, 2026 | 1.382B |
| September 09, 2026 | 1.379B |
| September 08, 2026 | 1.440B |
| September 04, 2026 | 1.426B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 7.107M |
| SCWorx Corp. | -1.154M |
| Health Catalyst, Inc. | 51.76M |
| Claritev Corp. | 5.171B |
| iSpecimen, Inc. | -3.171M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 8.536M |
| Revenue (Quarterly) | 200.41M |
| Total Expenses (Quarterly) | 191.88M |
| EPS Diluted (Quarterly) | 0.0245 |
| Gross Profit Margin (Quarterly) | 78.41% |
| Profit Margin (Quarterly) | 4.26% |
| Earnings Yield | 1.32% |
| Operating Earnings Yield | 7.68% |
| Normalized Earnings Yield | 2.421 |